ArticleThe Journal of clinical investigation2023

FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters.

Mengjiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.